AMRN should be able to get them to settle by making it clear that the only beneficary from their victory will be TEVA as AMRN will give them qualified generic status in the event any generic is accepted to enter the market.
Yet it is indisputable as I posted earlier that an in-person settlement conference was held with the Magistrate Judge, and a detailed settlement position paper was ordered to be submitted. The missing link is the contents, and whether the position was extortionate or reasonable?
News 
Market Data 
Discover 
AI
